A Phase III, Randomized, Multicentre, Open-Label, Concentration-Controlled, Safety and Efficacy Study of Voclosporin and Tacrolimus in Renal Transplantation.

Trial Profile

A Phase III, Randomized, Multicentre, Open-Label, Concentration-Controlled, Safety and Efficacy Study of Voclosporin and Tacrolimus in Renal Transplantation.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2014

At a glance

  • Drugs Voclosporin (Primary) ; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Registrational; Therapeutic Use
  • Acronyms INSPIRE
  • Sponsors Aurinia Pharmaceuticals
  • Most Recent Events

    • 16 Jan 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to withdrawn prior to recruitment.
    • 26 Nov 2012 Commencement for this trial has been cleared by the US FDA, according to an Isotechnika media release. Patient recruitment is expected to launch in the first half of 2013.
    • 11 Sep 2012 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top